QQ客服 官方微博 反馈留言

	Memantine for treatment of moderate or severe Alzheimer's disease patients in urban China: clinical and economic outcomes from a health economic model
	Hu, Shanlian; Yu, Xin; Chen, Shengdi; Clay, Emilie; Toumi, Mondher; Milea, Dominique
刊名	EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH
	2015
卷号	15期号:4
关键词	aggression Alzheimer's disease cost-saving disease burden memantine pharmacoeconomic
ISSN号	1473-7167
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4642753
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Hu, Shanlian,Yu, Xin,Chen, Shengdi,et al. Memantine for treatment of moderate or severe Alzheimer's disease patients in urban China: clinical and economic outcomes from a health economic model[J]. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH,2015,15(4).
APA	Hu, Shanlian,Yu, Xin,Chen, Shengdi,Clay, Emilie,Toumi, Mondher,&Milea, Dominique.(2015).Memantine for treatment of moderate or severe Alzheimer's disease patients in urban China: clinical and economic outcomes from a health economic model.EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH,15(4).
MLA	Hu, Shanlian,et al."Memantine for treatment of moderate or severe Alzheimer's disease patients in urban China: clinical and economic outcomes from a health economic model".EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH 15.4(2015).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。